Document is current
Any future updates will be listed below
-
Authors
Sun, Peng
Cen, Hong
Yang, Haiyan
Huang, Rui
Cai, Zhen
Gu, Xuekui
Bao, Hanying
Xu, Zusheng
Xu, Zuhong
Li, Zhi-Ming
-
Funding
Funding for this research was provided by:
National Science and Technology Major Project (2018ZX09734003)
National Natural Science Foundation of China (81872902, 82073917)
Guangzhou Municipal Science and Technology Program key projects (201804010485)
Sun Yat-sen University Cancer Center Clinical Research 308 Program (2014-fxy-106, 2016-fxy-079)
- License Information
-
More Information
Article History
Received: 30 October 2024
Accepted: 29 January 2025
First Online: 8 February 2025
Declarations
:
: The trial adhered to ethical guidelines, receiving approval from independent ethics committees or institutional review boards at each participating site. Written informed consent was obtained from all participants prior to their inclusion in the study.
: Not applicable.
: Hanying Bao, Zusheng Xu, and Zuhong Xu are employees of Shanghai Yingli Pharmaceutical Co., Ltd. The remaining authors have declared no conflicts of interest.
